Background: Prostate cancer represents the leading cause of male death across the world. A recent genome-wide association study (GWAS) identified five novel susceptibility loci for prostate cancer in the Japanese population. This study is to replicate and fine map the potential association of these five loci with prostate cancer in the Chinese Han population. Methods: In Phase I of the study, we tested the five single nucleotide polymorphisms (SNPs) which showed the strongest association evidence in the original GWAS in Japanese. The study sample consists of 1,169 Chinese Hans, comprising 483 patients and 686 healthy controls. Then in phase II, flanking SNPs of the successfully replicated SNPs in Phase I were genotyped and tested for associ...
Prostate cancer (PCa) is one of the most common cancers affecting men worldwide. It has different mo...
Five novel prostate cancer risk loci were identified in a recent genome-wide association study (GWAS...
Prostate cancer (PrCa) is the most frequently diagnosed male cancer in developed countries. We condu...
Prostate cancer represents the leading cause of male death across the world. A recent genome-wide as...
Prostate cancer represents the leading cause of male death across the world. A recent genome-wide as...
Genome-wide association studies (GWAS) have identifiedB100 genetic loci associated with prostate can...
Prostate cancer predisposition has been extensively investigated in European populations, but there ...
Prostate cancer predisposition has been extensively investigated in European populations, but there ...
Background: A recent genome-wide association study (GWAS) of prostate cancer in a Japanese populatio...
In European populations, 7 single nucleotide polymorphisms (SNPs) on chromosome 17q, 3 SNPs on 17q12...
Genome-wide association studies (GWAS) have identified ~170 genetic loci associated with prostate ca...
Prostate cancer (PrCa) is the most frequently diagnosed cancer in males in developed countries. To i...
Prostate cancer (PrCa) is the most frequently diagnosed male cancer in developed countries. We condu...
Prostate cancer (PrCa) is the most common non-skin cancer diagnosed among males in developed countri...
Prostate cancer (PrCa) is the most common non-skin cancer diagnosed among males in developed countri...
Prostate cancer (PCa) is one of the most common cancers affecting men worldwide. It has different mo...
Five novel prostate cancer risk loci were identified in a recent genome-wide association study (GWAS...
Prostate cancer (PrCa) is the most frequently diagnosed male cancer in developed countries. We condu...
Prostate cancer represents the leading cause of male death across the world. A recent genome-wide as...
Prostate cancer represents the leading cause of male death across the world. A recent genome-wide as...
Genome-wide association studies (GWAS) have identifiedB100 genetic loci associated with prostate can...
Prostate cancer predisposition has been extensively investigated in European populations, but there ...
Prostate cancer predisposition has been extensively investigated in European populations, but there ...
Background: A recent genome-wide association study (GWAS) of prostate cancer in a Japanese populatio...
In European populations, 7 single nucleotide polymorphisms (SNPs) on chromosome 17q, 3 SNPs on 17q12...
Genome-wide association studies (GWAS) have identified ~170 genetic loci associated with prostate ca...
Prostate cancer (PrCa) is the most frequently diagnosed cancer in males in developed countries. To i...
Prostate cancer (PrCa) is the most frequently diagnosed male cancer in developed countries. We condu...
Prostate cancer (PrCa) is the most common non-skin cancer diagnosed among males in developed countri...
Prostate cancer (PrCa) is the most common non-skin cancer diagnosed among males in developed countri...
Prostate cancer (PCa) is one of the most common cancers affecting men worldwide. It has different mo...
Five novel prostate cancer risk loci were identified in a recent genome-wide association study (GWAS...
Prostate cancer (PrCa) is the most frequently diagnosed male cancer in developed countries. We condu...